Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 6 (2009), Issue 3 (March)

1. Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer.
   J Clin Oncol, 27(7): 1091-9. [Abstract] [Full-text]
2. Patient screening by a physical therapist for nonmusculoskeletal hip pain.
   Phys Ther, 89(3): 248-56. [Abstract] [Full-text]
3. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence.
   Thorax, 64(3): 192-6. [Abstract] [Full-text]
4. A comprehensive assessment by tumor site of patient setup using daily MVCT imaging from more than 3,800 helical tomotherapy treatments.
   Int J Radiat Oncol Biol Phys, 73(4): 1260-9. [Abstract] [Full-text]
5. Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer.
   Int J Radiat Oncol Biol Phys, 73(4): 1235-42. [Abstract] [Full-text]
6. Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing.
   Int J Radiat Oncol Biol Phys, 73(4): 1228-34. [Abstract] [Full-text]
7. Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer.
   J Med Virol, 81(4): 722-7. [Abstract] [Full-text]
8. Toxocariasis mimicking liver, lung, and spinal cord metastases from retinoblastoma.
   Pediatr Infect Dis J, 28(3): 252-4. [Abstract] [Full-text]
9. Ablation of p120-catenin enhances invasion and metastasis of human lung cancer cells.
   Cancer Sci, 100(3): 441-8. [Abstract] [Full-text]
10. Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung.
    Cancer Sci, 100(3): 429-33. [Abstract] [Full-text]
11. Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial.
    Int J Radiat Oncol Biol Phys, 73(4): 1069-76. [Abstract] [Full-text]
12. Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the ERK/Slug pathway.
    Cell Signal, 21(5): 704-11. [Abstract] [Full-text]
13. RGS17, an overexpressed gene in human lung and prostate cancer, induces tumor cell proliferation through the cyclic AMP-PKA-CREB pathway.
    Cancer Res, 69(5): 2108-16. [Abstract] [Full-text]
14. Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells.
    Cancer Res, 69(5): 2117-25. [Abstract] [Full-text]
15. Depletion of cytosolic phospholipase A2 in bone marrow-derived macrophages protects against lung cancer progression and metastasis.
    Cancer Res, 69(5): 1733-8. [Abstract] [Full-text]
16. Clinical features of surgical resection for pulmonary metastasis from breast cancer.
    Eur J Surg Oncol, 35(4): 393-7. [Abstract] [Full-text]
17. Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy.
    Eur J Surg Oncol, 35(4): 356-61. [Abstract] [Full-text]
18. Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer.
    Cancer Lett, 276(2): 196-203. [Abstract] [Full-text]
19. Putative functional polymorphisms of MMP9 predict survival of NSCLC in a Chinese population.
    Int J Cancer, 124(9): 2172-8. [Abstract] [Full-text]
20. Murine osteosarcoma primary tumour growth and metastatic progression is maintained after marked suppression of serum insulin-like growth factor I.
    Int J Cancer, 124(9): 2042-9. [Abstract] [Full-text]
21. Estimation of the effects of smoking and DNA repair capacity on coefficients of a carcinogenesis model for lung cancer.
    Int J Cancer, 124(9): 2152-8. [Abstract] [Full-text]
22. Sex-specific familial risks of urinary bladder cancer and associated neoplasms in Sweden.
    Int J Cancer, 124(9): 2166-71. [Abstract] [Full-text]
23. The role of smoking and diet in explaining educational inequalities in lung cancer incidence.
    J Natl Cancer Inst, 101(5): 321-30. [Abstract] [Full-text]
24. Survival according to the site of bronchial microscopic residual disease after lung resection for non-small cell lung cancer.
    J Thorac Cardiovasc Surg, 137(3): 622-6. [Abstract] [Full-text]
25. CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival.
    J Thorac Cardiovasc Surg, 137(3): 615-21. [Abstract] [Full-text]
26. Stereotactic radiosurgery for the treatment of stage I non-small cell lung cancer in high-risk patients.
    J Thorac Cardiovasc Surg, 137(3): 597-604. [Abstract] [Full-text]
27. Expression of LKB1 tumor suppressor in non-small cell lung cancer determines sensitivity to 2-deoxyglucose.
    J Thorac Cardiovasc Surg, 137(3): 580-6. [Abstract] [Full-text]
28. Identification of mRNA splicing factors as the endothelial receptor for carbohydrate-dependent lung colonization of cancer cells.
    Proc Natl Acad Sci U S A, 106(9): 3095-100. [Abstract] [Full-text]
29. Characteristics of second primary lung malignancy in patients with known breast cancer.
    South Med J, 102(3): 269-74. [Abstract] [Full-text]
30. Association between sputum atypia and lung cancer risk in an occupational cohort in Yunnan, China.
    Chest, 135(3): 778-85. [Abstract] [Full-text]
31. Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil.
    J Clin Oncol, 27(8): 1227-34. [Abstract] [Full-text]
32. Overcoming CYP1A1/1A2 mediated induction of metabolism by escalating erlotinib dose in current smokers.
    J Clin Oncol, 27(8): 1220-6. [Abstract] [Full-text]
33. Necessity of centralisation of EBUS.
    Lung Cancer, 64(1): 127-8. [Abstract] [Full-text]
34. Bilateral subdural hemorrhage as a possible adverse event of gefitinib in a patient with non-small cell lung cancer.
    Lung Cancer, 64(1): 121-3. [Abstract] [Full-text]
35. Adult onset Still's disease after first cycle of pemetrexed and gemcitabine for non-small cell lung cancer.
    Lung Cancer, 64(1): 124-6. [Abstract] [Full-text]
36. Prediction of lymph node metastasis by gene expression profiling in patients with primary resected lung cancer.
    Lung Cancer, 64(1): 86-91. [Abstract] [Full-text]
37. Preoperative evaluation of the depth of chest wall invasion and the extent of combined resections in lung cancer patients.
    Lung Cancer, 64(1): 41-4. [Abstract] [Full-text]
38. Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy.
    Lung Cancer, 64(1): 98-104. [Abstract] [Full-text]
39. Chromosomal instability is a risk factor for poor prognosis of adenocarcinoma of the lung: Fluorescence in situ hybridization analysis of paraffin-embedded tissue from Korean patients.
    Lung Cancer, 64(1): 66-70. [Abstract] [Full-text]
40. Direct costs associated with the disease management of patients with unresectable advanced non-small-cell lung cancer in The Netherlands.
    Lung Cancer, 64(1): 110-6. [Abstract] [Full-text]
41. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
    Lung Cancer, 64(1): 92-7. [Abstract] [Full-text]
42. Prognostic relevance of TTF-1 and MMP-9 expression in advanced lung adenocarcinoma.
    Lung Cancer, 64(1): 105-9. [Abstract] [Full-text]
43. Comparative immunohistochemistry of L19 and F16 in non-small cell lung cancer and mesothelioma: two human antibodies investigated in clinical trials in patients with cancer.
    Lung Cancer, 64(1): 28-33. [Abstract] [Full-text]
44. Prognostic value and therapeutic consequences of vascular invasion in non-small cell lung carcinoma.
    Lung Cancer, 64(1): 71-8. [Abstract] [Full-text]
45. Radiotherapy for lung cancer: clinical impact of recent technical advances.
    Lung Cancer, 64(1): 1-8. [Abstract] [Full-text]
46. Transforming growth factor-beta1 increases cell migration and beta1 integrin up-regulation in human lung cancer cells.
    Lung Cancer, 64(1): 13-21. [Abstract] [Full-text]
47. Carbon ion radiotherapy for elderly patients 80 years and older with stage I non-small cell lung cancer.
    Lung Cancer, 64(1): 45-50. [Abstract] [Full-text]
48. Simultaneous expression of Cathepsins B and K in pulmonary adenocarcinomas and squamous cell carcinomas predicts poor recurrence-free and overall survival.
    Lung Cancer, 64(1): 79-85. [Abstract] [Full-text]
49. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT.
    Lung Cancer, 64(1): 34-40. [Abstract] [Full-text]
50. NAT2 fast acetylator genotypes are associated with an increased risk for lung cancer with wildtype epidermal growth factor receptors in Taiwan.
    Lung Cancer, 64(1): 9-12. [Abstract] [Full-text]
51. Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer.
    Lung Cancer, 64(1): 51-9. [Abstract] [Full-text]
52. Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer.
    Lung Cancer, 64(1): 60-5. [Abstract] [Full-text]
53. The retinoblastoma gene Rb and its family member p130 suppress lung adenocarcinoma induced by oncogenic K-Ras.
    Oncogene, 28(10): 1393-9. [Abstract] [Full-text]
54. Histoculture drug response assay for gefitinib in non-small-cell lung cancer.
    Gen Thorac Cardiovasc Surg, 57(3): 138-43. [Abstract] [Full-text]
55. Solitary cystic brain metastasis of small-cell lung carcinoma controlled by a stereotactically inserted Ommaya reservoir.
    Am J Med Sci, 337(3): 215-7. [Abstract] [Full-text]
56. Inhibitory heterotrimeric GTP-binding proteins inhibit hydrogen peroxide-induced apoptosis by up-regulation of Bcl-2 via NF-kappaB in H1299 human lung cancer cells.
    Biochem Biophys Res Commun, 381(2): 153-8. [Abstract] [Full-text]
57. Meta- and pooled analysis of GSTP1 polymorphism and lung cancer: a HuGE-GSEC review.
    Am J Epidemiol, 169(7): 802-14. [Abstract] [Full-text]
58. Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study.
    Am J Epidemiol, 169(7): 815-28. [Abstract] [Full-text]
59. Expression and significance of FRA-1 in non-small-cell lung cancer.
    Cancer Invest, 27(3): 353-9. [Abstract] [Full-text]
60. A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer.
    Clin Cancer Res, 15(6): 2158-65. [Abstract] [Full-text]
61. Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients.
    Clin Cancer Res, 15(6): 2076-84. [Abstract] [Full-text]
62. Forkhead box M1 expression in pulmonary squamous cell carcinoma: correlation with clinicopathologic features and its prognostic significance.
    Hum Pathol, 40(4): 464-70. [Abstract] [Full-text]
63. EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to EGFR inhibitors.
    Am J Clin Pathol, 131(4): 478-89. [Abstract] [Full-text]
64. Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping.
    Br J Cancer, 100(6): 985-92. [Abstract] [Full-text]
65. Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cells.
    Br J Cancer, 100(6): 941-9. [Abstract] [Full-text]
66. Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model.
    Am J Respir Cell Mol Biol, 40(4): 443-53. [Abstract] [Full-text]
67. Redox regulation in radiation-induced cytochrome c release from mitochondria of human lung carcinoma A549 cells.
    Cancer Lett, 277(1): 64-71. [Abstract] [Full-text]
68. In vivo evaluation of type 2 transglutaminase contribution to the metastasis formation in melanoma.
    Amino Acids, 36(4): 717-24. [Abstract] [Full-text]
69. Cancer risks in chemical production workers exposed to 2-mercaptobenzothiazole.
    Occup Environ Med, 66(4): 269-73. [Abstract] [Full-text]
70. Retrospective evaluation of the clinical and radiographic risk factors associated with severe pulmonary hemorrhage in first-line advanced, unresectable non-small-cell lung cancer treated with Carboplatin and Paclitaxel plus bevacizumab.
    J Clin Oncol, 27(9): 1405-12. [Abstract] [Full-text]
71. First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy.
    J Clin Oncol, 27(9): 1394-400. [Abstract] [Full-text]
72. Phase II trial of irinotecan and carboplatin for extensive or relapsed small-cell lung cancer.
    J Clin Oncol, 27(9): 1401-4. [Abstract] [Full-text]
73. Coordinated activation of candidate proto-oncogenes and cancer testes antigens via promoter demethylation in head and neck cancer and lung cancer.
    PLoS ONE, 4(3): e4961. [Abstract] [Full-text]
74. Ultrastructural proof of polyomavirus in Merkel cell carcinoma tumour cells and its absence in small cell carcinoma of the lung.
    PLoS ONE, 4(3): e4958. [Abstract] [Full-text]
75. Automated algorithm for quantifying the extent of cystic change on volumetric chest CT: initial results in Lymphangioleiomyomatosis.
    AJR Am J Roentgenol, 192(4): 1037-44. [Abstract] [Full-text]
76. Does incidental irradiation with doses below 50 gy effectively reduce isolated nodal failures in non-small-cell lung cancer: dose-response relationship.
    Int J Radiat Oncol Biol Phys, 73(5): 1391-6. [Abstract] [Full-text]
77. Potential dosimetric benefits of four-dimensional radiation treatment planning.
    Int J Radiat Oncol Biol Phys, 73(5): 1560-5. [Abstract] [Full-text]
78. Designing targets for elective nodal irradiation in lung cancer radiotherapy: a planning study.
    Int J Radiat Oncol Biol Phys, 73(5): 1397-403. [Abstract] [Full-text]
79. The effect of radiation dose and chemotherapy on overall survival in 237 patients with Stage III non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys, 73(5): 1383-90. [Abstract] [Full-text]
80. Comparison of spine, carina, and tumor as registration landmarks for volumetric image-guided lung radiotherapy.
    Int J Radiat Oncol Biol Phys, 73(5): 1404-13. [Abstract] [Full-text]
81. Apoptogenic effect of 7,8-diacetoxy-4-methylcoumarin and 7,8-diacetoxy-4-methylthiocoumarin in human lung adenocarcinoma cell line: role of NF-kappaB, Akt, ROS and MAP kinase pathway.
    Chem Biol Interact, 179(2): 363-74. [Abstract] [Full-text]
82. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) enhances invasiveness of lung cancer cells by up-regulating contactin-1 via the alpha7 nicotinic acetylcholine receptor/ERK signaling pathway.
    Chem Biol Interact, 179(2): 154-9. [Abstract] [Full-text]
83. Hospital characteristics associated with timeliness of care in veterans with lung cancer.
    Am J Respir Crit Care Med, 179(7): 595-600. [Abstract] [Full-text]
84. Trends in lung cancer death rates in Belgium and The Netherlands: a systematic analysis of temporal patterns.
    J Community Health, 34(3): 188-94. [Abstract] [Full-text]
85. Comparison of survival in advanced non-small cell lung cancer patients in the pre- and post-gefitinib eras.
    Oncology, 76(4): 239-46. [Abstract] [Full-text]
86. Molecular HPV typing as a diagnostic tool to discriminate primary from metastatic squamous cell carcinoma of the lung.
    Am J Surg Pathol, 33(4): 513-20. [Abstract] [Full-text]
87. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors.
    Am J Surg Pathol, 33(4): 626-32. [Abstract] [Full-text]
88. Pulmonary meningothelial-like nodules: new insights into a common but poorly understood entity.
    Am J Surg Pathol, 33(4): 487-95. [Abstract] [Full-text]
89. Genetic heterogeneity of EGFR mutation in pleomorphic carcinoma of the lung: response to gefitinib and clinical outcome.
    Jpn J Clin Oncol, 39(4): 267-70. [Abstract] [Full-text]
90. Management of tracheobronchial ulceration induced by high-dose brachytherapy.
    Ann Thorac Surg, 87(4): 1301-3. [Abstract] [Full-text]
91. Bronchoscopic blood injection reducing lung volume in lymphangioleiomyomatosis.
    Ann Thorac Surg, 87(4): 1266-8. [Abstract] [Full-text]
92. Treatment of primary melanoma of the lung monitored by 5-S-cysteinyldopa levels.
    Ann Thorac Surg, 87(4): 1264-6. [Abstract] [Full-text]
93. Acute superior vena cava occlusion after stenting of tracheoesophageal fistula.
    Ann Thorac Surg, 87(4): 1260-2. [Abstract] [Full-text]
94. Microthoracoscopic one-port method for lung cancer.
    Ann Thorac Surg, 87(4): 1250-2. [Abstract] [Full-text]
95. Radiofrequency ablation for the treatment of pulmonary metastases.
    Ann Thorac Surg, 87(4): 1030-6; discussion 1036-9. [Abstract] [Full-text]
96. Radiofrequency ablation of lung tumors: feasibility and safety.
    Ann Thorac Surg, 87(4): 1023-8. [Abstract] [Full-text]
97. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
    Ann Thorac Surg, 87(4): 1014-22. [Abstract] [Full-text]
98. Quality of life and mood in older patients after major lung resection.
    Ann Thorac Surg, 87(4): 1007-12; discussion 1012-3. [Abstract] [Full-text]
99. Surgeon specialty and long-term survival after pulmonary resection for lung cancer.
    Ann Thorac Surg, 87(4): 995-1004; discussion 1005-6. [Abstract] [Full-text]
100. A rare case of solitary plasmacytoma mimicking a primary lung tumor.
     Ann Thorac Surg, 87(4): e25-6. [Abstract] [Full-text]
101. Intraoperative pleural lavage cytology after lung resection as an independent prognostic factor for staging lung cancer.
     J Thorac Cardiovasc Surg, 137(4): 835-9. [Abstract] [Full-text]
102. Gender difference in survival of resected non-small cell lung cancer: histology-related phenomenon?
     J Thorac Cardiovasc Surg, 137(4): 807-12. [Abstract] [Full-text]
103. In vivo protective effect of crocetin on benzo(a)pyrene-induced lung cancer in Swiss albino mice.
     Phytother Res, 23(4): 533-9. [Abstract] [Full-text]
104. Cisplatin and weekly docetaxel with concurrent thoracic radiotherapy for locally advanced stage III non-small-cell lung cancer.
     Cancer Chemother Pharmacol, 63(6): 1091-6. [Abstract] [Full-text]
105. Inhibition of matrix metalloproteinase-2 enhances radiosensitivity by abrogating radiation-induced FoxM1-mediated G2/M arrest in A549 lung cancer cells.
     Int J Cancer, 124(10): 2468-77. [Abstract] [Full-text]
106. Epidermal growth factor receptor mutations in non-small cell lung cancer influence downstream Akt, MAPK and Stat3 signaling.
     J Cancer Res Clin Oncol, 135(5): 723-30. [Abstract] [Full-text]
107. CCR1 knockdown suppresses human non-small cell lung cancer cell invasion.
     J Cancer Res Clin Oncol, 135(5): 695-701. [Abstract] [Full-text]
108. Noncalcified lung nodules: volumetric assessment with thoracic CT.
     Radiology, 251(1): 26-37. [Abstract] [Full-text]
109. Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients.
     J Clin Oncol, 27(10): 1667-74. [Abstract] [Full-text]
110. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.
     J Clin Oncol, 27(10): 1579-84. [Abstract] [Full-text]
111. Identification of distant metastases with PET-CT in patients with suspected recurrent head and neck cancer.
     Laryngoscope, 119(4): 703-6. [Abstract] [Full-text]

© 2004-2010 Lung Cancer Research Today. All Rights Reserved.